[go: up one dir, main page]

GB201400951D0 - Novel drug formulation - Google Patents

Novel drug formulation

Info

Publication number
GB201400951D0
GB201400951D0 GB201400951A GB201400951A GB201400951D0 GB 201400951 D0 GB201400951 D0 GB 201400951D0 GB 201400951 A GB201400951 A GB 201400951A GB 201400951 A GB201400951 A GB 201400951A GB 201400951 D0 GB201400951 D0 GB 201400951D0
Authority
GB
United Kingdom
Prior art keywords
drug formulation
novel drug
novel
formulation
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201400951A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FAB PHARMA Sas
Original Assignee
FAB PHARMA Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FAB PHARMA Sas filed Critical FAB PHARMA Sas
Priority to GB201400951A priority Critical patent/GB201400951D0/en
Publication of GB201400951D0 publication Critical patent/GB201400951D0/en
Priority to KR1020167008205A priority patent/KR20160048922A/en
Priority to AU2014314122A priority patent/AU2014314122A1/en
Priority to JP2016537314A priority patent/JP2016529273A/en
Priority to PCT/EP2014/068428 priority patent/WO2015028637A1/en
Priority to MX2016002620A priority patent/MX2016002620A/en
Priority to US14/914,726 priority patent/US20160206577A1/en
Priority to EP14757932.0A priority patent/EP3038613A1/en
Priority to CN201480059220.XA priority patent/CN105705145A/en
Priority to IL244316A priority patent/IL244316A0/en
Ceased legal-status Critical Current

Links

GB201400951A 2013-08-29 2014-01-20 Novel drug formulation Ceased GB201400951D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB201400951A GB201400951D0 (en) 2014-01-20 2014-01-20 Novel drug formulation
CN201480059220.XA CN105705145A (en) 2013-08-29 2014-08-29 Novel drug formulation
PCT/EP2014/068428 WO2015028637A1 (en) 2013-08-29 2014-08-29 Novel drug formulation
AU2014314122A AU2014314122A1 (en) 2013-08-29 2014-08-29 Novel drug formulation
JP2016537314A JP2016529273A (en) 2013-08-29 2014-08-29 New drug formulation
KR1020167008205A KR20160048922A (en) 2013-08-29 2014-08-29 Novel drug formulation
MX2016002620A MX2016002620A (en) 2013-08-29 2014-08-29 Novel drug formulation.
US14/914,726 US20160206577A1 (en) 2013-08-29 2014-08-29 Novel drug formulation
EP14757932.0A EP3038613A1 (en) 2013-08-29 2014-08-29 Novel drug formulation
IL244316A IL244316A0 (en) 2013-08-29 2016-02-28 Novel drug formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201400951A GB201400951D0 (en) 2014-01-20 2014-01-20 Novel drug formulation

Publications (1)

Publication Number Publication Date
GB201400951D0 true GB201400951D0 (en) 2014-03-05

Family

ID=50239208

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201400951A Ceased GB201400951D0 (en) 2013-08-29 2014-01-20 Novel drug formulation

Country Status (1)

Country Link
GB (1) GB201400951D0 (en)

Similar Documents

Publication Publication Date Title
IL246978A0 (en) Novel pharmaceutical formulations
ZA201605300B (en) Pharmaceutical compositions comprising azd9291
GB201407934D0 (en) Formulation
GB201409471D0 (en) Pharmaceutical composition
SG11201702298VA (en) Pharmaceutical preparation
GB201409488D0 (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
ZA201508726B (en) Pharmaceutical composition
PL3200772T3 (en) Pharmaceutical compositions comprising alpelisib
ZA201502073B (en) Pharmaceutical composition
GB201407384D0 (en) Formulation
IL248835B (en) Ceritinib formulation
GB201506755D0 (en) Novel pharmaceutical formulation
GB201402448D0 (en) Novel formulation
GB201511301D0 (en) Formulation
PT3089740T (en) Pharmaceutical composition
IL251362A0 (en) Formulation
SG10201504332VA (en) Pharmaceutical Composition
GB201417589D0 (en) Pharmaceutical Formulations
GB201407741D0 (en) Novel drug formulation
GB201400951D0 (en) Novel drug formulation
GB201416536D0 (en) Formulation
GB201416274D0 (en) Formulation
GB201412754D0 (en) Formulation
GB201404773D0 (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)